ID19813A - Benzotiofen, formulasi yang mengandungnya, dan metodenya - Google Patents

Benzotiofen, formulasi yang mengandungnya, dan metodenya

Info

Publication number
ID19813A
ID19813A IDP970956A ID970956A ID19813A ID 19813 A ID19813 A ID 19813A ID P970956 A IDP970956 A ID P970956A ID 970956 A ID970956 A ID 970956A ID 19813 A ID19813 A ID 19813A
Authority
ID
Indonesia
Prior art keywords
benzotiofen
formulation
methods
Prior art date
Application number
IDP970956A
Other languages
English (en)
Inventor
Gordon Nelson Arbuthnot
Brian Weston Dalder
Kerry John Hartauer
Wayne Douglas Luke
Robert Eugene Stratford Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID19813(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9607110.5A external-priority patent/GB9607110D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID19813A publication Critical patent/ID19813A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thin Film Transistor (AREA)
IDP970956A 1996-03-26 1997-03-24 Benzotiofen, formulasi yang mengandungnya, dan metodenya ID19813A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1416796P 1996-03-26 1996-03-26
GBGB9607110.5A GB9607110D0 (en) 1996-04-04 1996-04-04 Benzothiopenes formulations containing same and methods

Publications (1)

Publication Number Publication Date
ID19813A true ID19813A (id) 1998-08-06

Family

ID=26309061

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970956A ID19813A (id) 1996-03-26 1997-03-24 Benzotiofen, formulasi yang mengandungnya, dan metodenya

Country Status (30)

Country Link
EP (2) EP2266560A1 (id)
JP (5) JP2000507268A (id)
CN (1) CN1162153C (id)
AR (1) AR006387A1 (id)
AT (1) ATE464897T1 (id)
AU (1) AU723797B2 (id)
BR (1) BR9708248A (id)
CA (1) CA2250191C (id)
CO (1) CO4780022A1 (id)
CZ (1) CZ300341B6 (id)
DE (1) DE69739855D1 (id)
DK (1) DK0910369T3 (id)
EA (1) EA001257B1 (id)
ES (1) ES2341399T3 (id)
HK (1) HK1020671A1 (id)
ID (1) ID19813A (id)
IL (2) IL126320A (id)
ME (2) ME00074B (id)
MY (1) MY115533A (id)
NO (1) NO320894B1 (id)
NZ (1) NZ332036A (id)
PL (1) PL191148B1 (id)
PT (1) PT910369E (id)
RO (1) RO121117B1 (id)
SI (1) SI0910369T1 (id)
TR (1) TR199801915T2 (id)
TW (1) TW513421B (id)
UA (1) UA57596C2 (id)
WO (1) WO1997035571A1 (id)
YU (1) YU41898A (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2341399T3 (es) * 1996-03-26 2010-06-18 Eli Lilly And Company Benziotofenos, formulaciones que contienen los mismos y procedimientos.
CA2219377A1 (en) * 1996-10-30 1998-04-30 Eli Lilly And Company Improvements in or relating to the prophylaxis of breast cancer
ZA992858B (en) 1996-10-30 1999-07-29 Lilly Co Eli Methods of preventing breast cancer.
EP1546138B1 (en) * 2002-09-30 2012-01-18 A/S GEA Farmaceutisk Fabrik Raloxifene l-lactate or a hemihydrate thereof, their uses, pharmaceutical compositions and preparation processes
WO2008047105A1 (en) 2006-10-17 2008-04-24 Cipla Limited Crystalline form of benzothiophene compound and process for preparation thereof
EP2242483B1 (en) * 2007-12-21 2013-02-20 Synthon B.V. Raloxifene composition
ES2624557T3 (es) * 2008-12-11 2017-07-14 Besins Healthcare Luxembourg Sarl Composiciones farmacéuticas transdérmicas que comprenden un SERM
ES2437916T3 (es) 2009-07-02 2014-01-15 Synthon B.V. Composición de raloxifeno
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
GB201515387D0 (en) * 2015-08-28 2015-10-14 Amazentis Sa Compositions
GB201515391D0 (en) * 2015-08-28 2015-10-14 Amazentis Sa Compositions
PL3251661T3 (pl) 2016-05-30 2021-06-14 Sun Pharmaceutical Industries Limited Kompozycja raloksyfenu do posypywania

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
JPS63112519A (ja) * 1986-10-28 1988-05-17 Shin Etsu Chem Co Ltd ニフエジピン製剤の製造方法
NL9000634A (nl) * 1990-03-20 1991-10-16 Catharina Ziekenhuis Stichting Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CA2124568C (en) * 1992-10-09 2003-11-11 Yoshiaki Yano Method for producing microgranulated particle
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5482950A (en) * 1993-10-15 1996-01-09 Eli Lilly And Company Methods for lowering serum cholesterol
CA2176130A1 (en) * 1993-12-21 1995-06-29 Thomas Alan Crowell Non-peptide tachykinin receptor antagonists
IL112746A (en) * 1994-03-02 1999-12-31 Lilly Co Eli Orally administrable pharmaceutical formulation comprising raloxifene hydrochoride
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US6723739B1 (en) 1994-05-20 2004-04-20 Eli Lilly And Company Glucopyranoside benzothiophenes
US5494920A (en) * 1994-08-22 1996-02-27 Eli Lilly And Company Methods of inhibiting viral replication
CO4410191A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US5494929A (en) * 1995-01-12 1996-02-27 Eli Lilly And Company Methods of inhibiting growth hormone effects
US5532254A (en) * 1995-06-07 1996-07-02 Eli Lilly And Company Modulation of calcium channels using benzothiophenes
ES2341399T3 (es) * 1996-03-26 2010-06-18 Eli Lilly And Company Benziotofenos, formulaciones que contienen los mismos y procedimientos.

Also Published As

Publication number Publication date
PT910369E (pt) 2010-06-04
WO1997035571A1 (en) 1997-10-02
AR006387A1 (es) 1999-08-25
NO984444D0 (no) 1998-09-24
CZ305398A3 (cs) 1999-05-12
ME00074B (me) 2010-10-10
IL126320A (en) 2001-08-08
NO320894B1 (no) 2006-02-06
RO121117B1 (ro) 2006-12-29
JP6095821B2 (ja) 2017-03-15
DE69739855D1 (de) 2010-06-02
EP2266560A1 (en) 2010-12-29
CO4780022A1 (es) 1999-05-26
DK0910369T3 (da) 2010-07-26
JP2000507268A (ja) 2000-06-13
IL140742A0 (en) 2002-02-10
PL329051A1 (en) 1999-03-01
JP2009019057A (ja) 2009-01-29
AU2215497A (en) 1997-10-17
SI0910369T1 (sl) 2010-08-31
JP2015157865A (ja) 2015-09-03
IL140742A (en) 2012-02-29
CA2250191C (en) 2005-11-15
AU723797B2 (en) 2000-09-07
EA199800865A1 (ru) 1999-02-25
YU41898A (sh) 1999-07-28
CN1213967A (zh) 1999-04-14
CZ300341B6 (cs) 2009-04-22
EP0910369A1 (en) 1999-04-28
EP0910369B1 (en) 2010-04-21
TW513421B (en) 2002-12-11
BR9708248A (pt) 1999-07-27
JP2016106159A (ja) 2016-06-16
JP2013166797A (ja) 2013-08-29
TR199801915T2 (xx) 1998-12-21
IL126320A0 (en) 1999-05-09
ES2341399T3 (es) 2010-06-18
CN1162153C (zh) 2004-08-18
ATE464897T1 (de) 2010-05-15
JP6095725B2 (ja) 2017-03-15
NZ332036A (en) 1999-04-29
PL191148B1 (pl) 2006-03-31
EA001257B1 (ru) 2000-12-25
UA57596C2 (uk) 2003-06-16
MY115533A (en) 2003-07-31
HK1020671A1 (en) 2000-05-19
MEP18308A (en) 2010-06-10
NO984444L (no) 1998-11-26
EP0910369A4 (en) 2001-03-21
CA2250191A1 (en) 1997-10-02

Similar Documents

Publication Publication Date Title
ID23807A (id) Metoda dan komposisi yang mengandung-semen untuk digunakan dalam bawah tanah
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ID25528A (id) Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
ID19422A (id) Piridina dan bifenil tersubstitusi
ID18046A (id) Senyawa siklik campuran, pembuatan dan penngunaannya.
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID23439A (id) Turunan-turunan 3-piperidil-4-oksokuinazolin dan komposisi-komposisi farmasi yang sama
ID25543A (id) Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
ID16202A (id) Sistem pemesanan yang memberikan penjelajahan sleksifer dan metodanya
DE69709613D1 (de) Schminkdose
FI960450A (fi) Lukitusteline
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID29052A (id) Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID21770A (id) Plester yang mengandung felbinak
ID19813A (id) Benzotiofen, formulasi yang mengandungnya, dan metodenya
ID23258A (id) Penarik pemberian-menyilang dan metodenya
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID24633A (id) Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya
PT811593E (pt) Agentes insecticidas e acaricidas 1,4-diaril-2-fluor-2-buteno
DE69712037D1 (de) Mischkopfdüse
NL1007839A1 (nl) Formulering en gebruik.
ID26780A (id) Senyawa-senyawa tienopiridina, hasil dan kegunaannya